Clinical trials
Phase 1/2 Appendiceal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allist Pharmaceuticals, Inc. | 1 |
| Cybrexa Therapeutics | 1 |
| Ludwig Institute for Cancer Research | 1 |
| Revolution Medicines, Inc. | 1 |
| Verastem, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Appendiceal Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Pancreatic Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 51 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.